More2life has announced the expansion of its range of high LTV products, including its Tailored Enhanced and Maxi Choice offerings.
The lender states that Tailor Enhanced is designed to provide eligible clients with expanded access to some of the highest LTVs available in the market. it says that the product dispenses with complicated paperwork and instead requires the clients to answer 13 medical and lifestyle questions. Once the questionnaire is processed, eligible clients could gain access to enhanced LTVs up to 54%.
Clients who meet one or more of a set number of conditions will be eligible for the product. These conditions include the following:
- If the client is an active smoker
- If the client has experienced cardiovascular problems
- If the client has a formal diagnosis of angina
More2life will also roll out the Maxi Choice range, which is aimed at older borrowers across the UK market. The Max Super 1 and Super 2 products will be relaunched, and the maximum age on all Maxi plans will shoot up from 84 years old to 89 years and 364 days.
In addition, the max loan will increase from £950k to £1.5m and the maximum property value will be uncapped. Drawdown plans will also be relaunched. All Maxi plan rates have also decreased, widening access to the product.
The new products are currently available and can be viewed through more2life’s fastpath system.
Ben Waugh (pictured), managing director at more2life, said: “As more and more older UK homeowners look to use equity release as a tool to enhance their income and fund financial gifts for younger relatives, it’s important that borrowers can access a wide spectrum of competitive LTV options.
“At more2life, we pride ourselves on providing a wide range of options for customers, and the relaunch of our Tailored Enhanced and Maxi Choice ranges is the latest step in our long-term strategy to set a new benchmark in later life lending offerings.
“Product ranges will continue to evolve, so customers must seek a comprehensive conversation with an expert, who can often provide access to suitable products that are otherwise unavailable on the direct market.”